Search results
Author(s):
Naima Maqsood
,
Jeff Healey
Added:
5 months ago
AHA 2023 — Dr Naima Maqsood, CardioNerds ambassador (Temple University Hospital, US) interviews investigator, Dr Jeff Healey (McMaster University, CA) to outline the findings from a phase 4 trial of apixaban to reduce thromboembolism in patients with subclinical atrial fibrillation (AF).ARTESiA (NCT01938248) aims to determine if apixaban in combination with aspirin can reduce the instance of…
View more
Author(s):
Ramy Doss
,
Chiadi Ndumele
Added:
5 months ago
AHA 2023 — CardioNerds Ambassador, Dr Ramy Doss (Nazareth Hospital, US) is joined by Dr Chiadi E Ndumele (Johns Hopkins University, US) to talk about AHA's Presidential Advisory on Cardiovascular-Kidney-Metabolic Health (CKM).The presidential advisory focuses on the cardiovascular-kidney-metabolic (CKM) syndrome, a systemic disorder connecting heart disease, kidney disease, diabetes and obesity…
View more
Author(s):
Mark Huffman
,
Vallerie V McLaughlin
Added:
3 years ago
Idiopathic pulmonary arterial hypertension (formerly referred to as primary pulmonary hypertension) is an uncommon yet progressively fatal disease defined by the presence of mean pulmonary artery pressure greater than 25mmHg at rest or greater than 30mmHg with exercise as tested by right heart catheterization in the absence of other etiologies for pulmonary hypertension. Across several studied…
View more
Author(s):
Ijeoma Isiadinso
,
Nanette K Wenger
Added:
3 years ago
Prevalence of Cardiovascular Disease
CVD is the leading cause of death in Europe and the United States. CVD mortality is on the decline in many countries, and in several European countries, cancer has now surpassed CVD as the leading cause of death.1 However, CVD remains the leading cause of death for both men and women in the United States and results in more female deaths than cancer, lung…
View more
Author(s):
Hisham A Badreldin
,
Khalid bin Saleh
,
Majed Al-Yami
Added:
3 years ago
WRAP-IT
The Worldwide Randomized Antibiotic Envelope Infection Prevention Trial (WRAP-IT) was a prospective multicenter study to determine the safety and efficacy of an absorbable surgical mesh envelope containing two antibiotics (minocycline and rifampin) in reducing infection incidence in patients with cardiac implantable electronic devices compared to standard care.1 Approximately 7,000…
View more
Author(s):
William McIntyre
Added:
1 week ago
EHRA 24 - Investigator, Dr William McIntyre (Population Health Research Institute, CA) joins us to discuss the findings from a substudy of ARTESiA (NCT01938248).ARTESiA was a randomized, parallel assignment clinical trial which aimed to assess if apixaban could reduce the risk of ischemic stroke and systemic embolism in patients with subclinical atrial fibrillation (AF) and additional risk…
View more
Author(s):
RJ Kanter
Added:
3 years ago
Introduction
Compared with patients with structurally normal hearts, there is an even greater need to suppress pathologic tachycardias in patients with congenital heart disease. The decrease in diastolic filling time and potential loss of atrioventricular (AV) synchrony are more poorly tolerated in these patients, proportionate to the degree of underlying systolic and diastolic dysfunction…
View more
Author(s):
Shamai A Grossman
Added:
3 years ago
Introduction
Congestive heart failure (CHF) is an imbalance in pump function in which the heart fails to maintain the circulation of blood adequately. The most severe manifestation of CHF, pulmonary edema, develops when this imbalance causes an increase in lung fluid secondary to leakage from pulmonary capillaries into the interstitium and alveoli of the lung.
CHF can be categorized as forward…
View more
Novel Oral Antiplatelet Agents
Author(s):
Suzanne J Baron
,
Robert P Giugliano
Added:
3 years ago
Article